Valuation: SOL SpA

Market Cap 4.77B 5.57B 4.47B 4.08B 7.71B 531B 7.78B 52.73B 20.53B 268B 20.9B 20.45B 887B P/E 2026 *
25.9x
P/E 2027 * 24.1x
Enterprise Value 5.22B 6.09B 4.89B 4.46B 8.43B 580B 8.51B 57.65B 22.44B 293B 22.86B 22.36B 970B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.52x
Free-Float
40.02%
Yield 2026 *
0.94%
Yield 2027 * 1%
Manager TitleAgeSince
Chief Executive Officer 65 1990-09-03
Chief Executive Officer 68 1990-05-14
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 68 1990-05-14
Director/Board Member 65 1990-09-03
Director/Board Member 67 1998-04-26
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 5.58B
-0.58%+1.77%+1.96%+27.68% 226B
-0.78%+0.20%+3.29%+5.39% 68.2B
-1.23%-14.91%+488.94%+636.21% 19.69B
-0.80%-1.94%+3.47%+68.16% 15.53B
-2.31%-15.81%+209.20%+235.19% 6.89B
-0.69%-3.50%+3.15%+9.71% 5.82B
-1.91%-11.18%+52.30%+143.95% 5.76B
-0.19%-1.50%+2.14%+109.98% 5.58B
-0.20%+0.04%+0.73%+39.87% 3.58B
Average -0.87%-4.19%+85.02%+141.79% 39.66B
Weighted average by Cap. -0.70%-0.07%+33.96%+65.75%

Financials

2026 *2027 *
Net sales 1.92B 2.24B 1.8B 1.64B 3.1B 213B 3.13B 21.18B 8.25B 108B 8.4B 8.21B 356B 2.05B 2.39B 1.92B 1.76B 3.31B 228B 3.35B 22.68B 8.83B 115B 8.99B 8.8B 381B
Net income 192M 224M 180M 165M 311M 21.4B 314M 2.13B 828M 10.8B 843M 825M 35.76B 206M 241M 193M 176M 333M 22.94B 336M 2.28B 887M 11.57B 903M 884M 38.33B
Net Debt 445M 520M 417M 381M 719M 49.54B 726M 4.92B 1.92B 24.99B 1.95B 1.91B 82.77B 399M 466M 374M 342M 645M 44.44B 652M 4.42B 1.72B 22.42B 1.75B 1.71B 74.26B
Logo SOL SpA
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
52.60EUR
Average target price
61.62EUR
Spread / Average Target
+17.16%

Quarterly revenue - Rate of surprise